Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases.
AUTOR(ES)
Fernandez-Rodriguez, A
RESUMO
The aminoglycoside-modifying enzymes present in the first 120 clinical isolates harboring extended-spectrum beta-lactamases isolated in Spain were studied. Most of these isolates (84%) were gentamicin resistant. The enzymes most frequently associated and cotransferred with SHV-2 or TEM-type beta-lactamases were AAC(3)V, APH(3"), and APH(3')I.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=284369Documentos Relacionados
- Extended-spectrum beta-lactamases.
- More extended-spectrum beta-lactamases.
- In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases.
- Properties of plasmids responsible for production of extended-spectrum beta-lactamases.
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases.
